Skip to main content

Hydrochlorothiazide / spironolactone Side Effects

Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.

Applies to hydrochlorothiazide / spironolactone: oral tablet.

Warning

Oral route (Tablet)

This drug has been reported to be tumorigenic in rat chronic toxicity studies. Use this drug only as indicated. Fixed-dose spironolactone/hydrochlorothiazide is not indicated for the initial treatment of edema or hypertension.

Serious side effects

Along with its needed effects, hydrochlorothiazide / spironolactone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hydrochlorothiazide / spironolactone:

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking hydrochlorothiazide / spironolactone:

Symptoms of overdose

Other side effects

Some side effects of hydrochlorothiazide / spironolactone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to hydrochlorothiazide / spironolactone: oral tablet.

Endocrine

Spironolactone:

Frequency not reported: Gynecomastia[Ref]

Other

Hydrochlorothiazide:

Frequency not reported: Weakness, fever, vertigo

Spironolactone:

Frequency not reported: Breast pain, fever[Ref]

Cardiovascular

Hydrochlorothiazide:

Frequency not reported: Hypotension, orthostatic hypotension, necrotizing angitis, vasculitis

Spironolactone:

Frequency not reported: Vasculitis[Ref]

Hepatic

Hydrochlorothiazide:

Frequency not reported: Pancreatitis, intrahepatic cholestatic jaundice

Spironolactone:

Frequency not reported: Mixed cholestatic/hepatocellular toxicity[Ref]

Gastrointestinal

Hydrochlorothiazide:

Frequency not reported: Diarrhea, vomiting, sialoadenitis, cramping, constipation, gastric irritation, nausea

Spironolactone:

Frequency not reported: Gastric bleeding, ulceration, gastritis, diarrhea, cramping, nausea, vomiting[Ref]

Metabolic

Hydrochlorothiazide:

Frequency not reported: Anorexia, electrolyte imbalance, hyperglycemia, hyperuricemia

Spironolactone:

Frequency not reported: Hyperkalemia, electrolyte disturbances[Ref]

Ocular

Hydrochlorothiazide:

Frequency not reported: Acute myopia, acute angle closure glaucoma, transient blurred vision, xanthopsia[Ref]

Hematologic

Hydrochlorothiazide:

Frequency not reported: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia

Spironolactone:

Frequency not reported: Leukopenia, agranulocytosis, thrombocytopenia[Ref]

Immunologic

Hydrochlorothiazide:

Frequency not reported: Anaphylactic reactions

Spironolactone:

Frequency not reported: Anaphylactic reactions[Ref]

Dermatologic

Hydrochlorothiazide:

Frequency not reported: Cutaneous vasculitis, photosensitivity, urticaria, rash, purpura, erythema multiforme, pruritus

Spironolactone:

Frequency not reported: Urticaria, maculopapular or erythematous cutaneous eruptions, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms, alopecia, pruritus

Postmarketing: Non-melanoma skin cancer[Ref]

Respiratory

Hydrochlorothiazide:

Frequency not reported: Pneumonitis, pulmonary edema[Ref]

Genitourinary

Hydrochlorothiazide:

Frequency not reported: Glycosuria

Spironolactone:

Frequency not reported: Inability to achieve or maintain erection, irregular menses or amenorrhea, postmenopausal bleeding[Ref]

Musculoskeletal

Hydrochlorothiazide:

Frequency not reported: Muscle spasm

Spironolactone:

Frequency not reported: Leg cramps[Ref]

Nervous system

Hydrochlorothiazide:

Frequency not reported: Paresthesias, dizziness, headache

Spironolactone:

Frequency not reported: Lethargy, ataxia, dizziness, headache, drowsiness[Ref]

Psychiatric

Hydrochlorothiazide:

Frequency not reported: Restlessness

Spironolactone:

Frequency not reported: Mental confusion[Ref]

Renal

Hydrochlorothiazide:

Frequency not reported: Renal failure, renal dysfunction, interstitial nephritis

Spironolactone:

Frequency not reported: Renal dysfunction, renal failure[Ref]

Oncologic

Spironolactone:

Frequency not reported: Carcinoma of the breast[Ref]

References

1. Product Information. Aldactazide (hydrochlorothiazide-spironolactone). Pfizer U.S. Pharmaceuticals Group. 2015.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.